May Tcha

May Tcha serves as the Disclosure & Transparency Manager at Gilead Sciences, where she plays a pivotal role in ensuring that clinical research activities are conducted with the utmost integrity and transparency. With a robust background in clinical research, May is dedicated to improving patient outcomes through meticulous oversight of clinical trial disclosures. Her expertise encompasses the execution of high-quality regulatory deliverables, including the registration and results posting of clinical studies on platforms such as ClinicalTrials.gov, EUCTR, and ENCePP.

In her current role, May is responsible for managing the registrations of new protocols and maintaining comprehensive protocol records, ensuring compliance with FDA regulations and international guidelines. She collaborates cross-functionally with various departments, including clinical operations, regulatory affairs, and legal teams, to ensure that all deliverables meet stringent regulatory requirements. Her ability to navigate the complexities of clinical trial transparency is enhanced by her strong organizational skills and attention to detail, which are essential in a fast-paced, deadline-driven environment.

May’s technical proficiency extends to her familiarity with handling controlled substances and cytotoxic compounds, as well as her compliance with DEA, cGMP, and GLP regulations. She is adept at utilizing advanced analytical techniques, including UPLC, GC, FTIR, and UV/Vis spectroscopy, to support her work in clinical research. With her commitment to ethical standards and regulatory compliance, May Tcha is a valuable asset to Gilead Sciences, driving forward the mission to enhance lives through innovative therapies and transparent clinical research practices.